Therapy for Acute Hepatitis C
- 15 November 2001
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (20) , 1495-1497
- https://doi.org/10.1056/nejm200111153452013
Abstract
Infection with the hepatitis C virus (HCV) is now the most frequent cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma in the United States and most Western nations.13 Population-based surveys show that 1 to 2 percent of adults in the United States are chronically infected with HCV.2 Although hepatitis C has been described as an epidemic and a national emergency, the epidemic reflects the identification of chronic cases rather than a large outbreak of new cases.Acute hepatitis C is no longer very common in the United States. The incidence has decreased from a peak level of 250,000 to . . .Keywords
This publication has 15 references indexed in Scilit:
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United StatesHepatology, 2000
- Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis CAnnals of Internal Medicine, 2000
- 4 Acute hepatitis CPublished by Elsevier ,2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Hepatocellular carcinomaHepatology, 1998
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 1997